Decreased CD5(+) B Cells in Active ANCA Vasculitis and Relapse after Rituximab

BACKGROUND AND OBJECTIVES: B cell significance in ANCA disease pathogenesis is underscored by the finding that ANCA alone can cause disease in mouse models and by the effectiveness of rituximab as therapy in ANCA-small vessel vasculitis (ANCA-SVV). To avoid infections and adverse events from therapy...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Bunch, Donna O’Dell, McGregor, JulieAnne G., Khandoobhai, Nirmal B., Aybar, Lydia T., Burkart, Madelyn E., Hu, Yichun, Hogan, Susan L., Poulton, Caroline J., Berg, Elisabeth A., Falk, Ronald J., Nachman, Patrick H.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Nephrology 2013
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3586963/
https://ncbi.nlm.nih.gov/pubmed/23293123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.03950412
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars